Connect with us

News

NAFDAC hopes to use Chloroquine to tackle coronavirus

Published

on

NAFDAC suspends new tariffs for drugs, food, others

In search of a cure to the coronavirus pandemic, the National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine.

The agency said it would love to subject the drug for clinical trials in tackling COVID-19.

This was made known by Director-General (DG) of NAFDAC, Mojisola Adeyeye on Friday at the agency’s headquarters in Lagos.

She however, noted that NAFDAC was not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.

She said “In the case of Chloroquine, it has been demonstrated in the literature and with clinical research which is still ongoing, that Chloroquine is superior to the Placebo.

NAFDAC is not approving Chloroquine as a product that can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.

“Therefore the medicine is being approved just for the clinical trials.”

Consequently, she urged experts and researchers interested in conducting a clinical trial on Chloroquine to approach approved outlets

Adding that a drug company has been given an approval to produce chloroquine in batches she said:

“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial.”

READ ALSO: CORONAVIRUS: Austria, Sweden join 13 other countries on Nigeria’s travel ban

Meanwhile, she said Nigerians should not use “chloroquine as anti-malaria because of the resistance that has been proven to develop in the past after the use of chloroquine in the population.”

The President of the United States, was quoted to have recently claimed that Chloroquine could cure the deadly coronavirus.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now